Previous 10 | Next 10 |
Advances Integrated Technology Strategy Through Enhanced Revenue Intelligence and Expanded Automation Opportunity R1 to Host Conference Call Today at 7:00 a.m. ET MURRAY, Utah and ATLANTA, Jan. 10, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1 ...
MURRAY, Utah, Dec. 31, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 40th Annual J.P. Morg...
Streamline Health Solutions, Inc. is a relatively unknown, high-growth investment opportunity in the medical billing space trading at a ~ $68 million market cap. Streamline’s acquisition of Avelead will double current sales immediately and create an opportunity for cross-sellin...
MURRAY, Utah, Nov. 16, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced a new patient billing partnership with California-based Adven...
R1 RCM Inc. (RCM) Q3 2021 Earnings Conference Call November 2, 2021 08:00 ET Company Participants Atif Rahim - Investor Relations Joe Flanagan - President and Chief Executive Officer Rachel Wilson - Executive Vice President and Chief Financial Office Conference Call Participants Michael Chern...
Image source: The Motley Fool. R1 RCM inc (NASDAQ: RCM) Q3 2021 Earnings Call Nov 2, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: R1 RCM inc (RCM) Q3 2021 Earnings Call Transcript
R1 RCM (NASDAQ:RCM) board authorized the repurchase of up to $200M of its common stock; repurchase program will be funded with cash on hand. "Our durable cash flow generation provides ample capacity to opportunistically conduct share repurchases as a component of our capital allocation s...
R1 RCM (NASDAQ:RCM): Q3 GAAP EPS of $0.05 misses by $0.03. Revenue of $379.7M (+23.6% Y/Y) beats by $7.11M. Press Release For further details see: R1 RCM EPS misses by $0.03, beats on revenue
MURRAY, Utah, Nov. 02, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2021. ...
MURRAY, Utah, Nov. 02, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) today announced that its Board of Directors has authorized the repurchase of up to $200 million of the company’s common stock. The repurchase program will be funded with cash on hand and will be executed consis...
News, Short Squeeze, Breakout and More Instantly...
MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A ...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
2024-07-09 09:00:05 ET George Hill from Deutsche Bank issued a price target of $16.00 for RCM on 2024-07-09 07:36:00. The adjusted price target was set to $16.00. At the time of the announcement, RCM was trading at $12.66. The overall price target consensus is at $19.00 ...